Indoles Stocks List
Related Industries: Biotechnology
Related Stock Lists:
Acne
Alipogene Tiparvovec
Analgesics
Biopharmaceutical
Cardiovascular Disease
Chemical Compounds
Erythromelalgia
Gene Therapy
Glybera
Knee
Lipase
Lipoprotein
Lipoprotein Lipase Deficiency
Neuropathic Pain
Organic Compounds
Osteoarthritis
Pain
Pharmaceutical Industries
Postherpetic Neuralgia
Teva Pharmaceutical Industries
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IBRN | D | iShares Neuroscience and Healthcare ETF | 3.83 | |
SBIO | B | ALPS Medical Breakthroughs ETF | 1.93 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 0.77 | |
MMSC | C | First Trust Multi-Manager Small | 0.75 | |
GDOC | A | Goldman Sachs Future Health Care Equity ETF | 0.43 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Acne
Alipogene Tiparvovec
Analgesics
Biopharmaceutical
Cardiovascular Disease
Chemical Compounds
Erythromelalgia
Gene Therapy
Glybera
Knee
Lipase
Lipoprotein
Lipoprotein Lipase Deficiency
Neuropathic Pain
Organic Compounds
Osteoarthritis
Pain
Pharmaceutical Industries
Postherpetic Neuralgia
Teva Pharmaceutical Industries
- Indoles
Indole is an aromatic heterocyclic organic compound with formula C8H7N. It has a bicyclic structure, consisting of a six-membered benzene ring fused to a five-membered pyrrole ring. Indole is widely distributed in the natural environment and can be produced by a variety of bacteria. As an intercellular signal molecule, indole regulates various aspects of bacterial physiology, including spore formation, plasmid stability, resistance to drugs, biofilm formation, and virulence. The amino acid tryptophan is an indole derivative and the precursor of the neurotransmitter serotonin.
Popular Now
Recent Comments
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
From the Blog
Featured Articles